An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.114265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Banghui Liu und 23 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regener…. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Mutation, Antibodies, Viral. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Municipal Science and Technology Bureau, Chinese Academy of Sciences.
Abstract (Originalsprache)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein continues to evolve antigenically, impacting antibody immunity. D1F6, an affinity-matured non-stereotypic VH1-2 antibody isolated from a patient infected with the SARS-CoV-2 ancestral strain, effectively neutralizes most Omicron variants tested, including XBB.1.5. We identify that D1F6 in the immunoglobulin G (IgG) form is able to overcome the effect of most Omicron mutations through its avidity-enhanced multivalent S-trimer binding. Cryo-electron microscopy (cryo-EM) and biochemical analyses show that three simultaneous epitope mutations are generally needed to substantially disrupt the multivalent S-trimer binding by D1F6 IgG. Antigenic mutations at spike positions 346, 444, and 445, which appeared in the latest variants, have little effect on D1F6 binding individually. However, these mutations are able to act synergistically with earlier Omicron mutations to impair neutralization by affecting the interaction between D1F6 IgG and the S-trimer. These results provide insight into the mechanism by which accumulated antigenic mutations facilitate evasion of affinity-matured antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Disease, CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong Provincial Key Laboratory of Biocomputing, G…
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
- Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- Guangzhou Laboratory & Bioland Laboratory, Guangzhou, China.
- Bioland Laboratory (Guangzhou Regenerative Medicine and Health - Guangdong Laboratory), Guangzhou, China.
- Guangzhou Laboratory & Bioland Laboratory, Guangzhou, China. Electronic address: chen_ling@gibh.ac.cn.
Förderung
- National Natural Science Foundation of China
- Guangzhou Municipal Science and Technology Bureau
- Chinese Academy of Sciences
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Liu, B., Niu, X., Deng, Y., Zhang, Z., Wang, Y., Gao, X., Liang, H., Li, Z., Wang, Q., Cheng, Y., Chen, Q., Huang, S., Pan, Y., Su, M., Lin, X., Niu, C., Chen, Y., Yang, W., Zhang, Y., …, & Xiong, X. (2024). An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114265
Vancouver
Liu B, Niu X, Deng Y, Zhang Z, Wang Y, Gao X, et al. An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114265
BibTeX
@article{Liu2024,
author = {Liu, Banghui and Niu, Xuefeng and Deng, Yijun and Zhang, Zhaoyong and Wang, Yanqun and Gao, Xijie and Liang, Huan and Li, Zimu and Wang, Qian and Cheng, Yuanyi and Chen, Qiuluan and Huang, Shuangshuang and Pan, Yingxian and Su, Mengzhen and Lin, Xiancheng and Niu, Chuanying and Chen, Yinglin and Yang, Wenyi and Zhang, Yudi and Yan, Qihong and He, Jun and Zhao, Jincun and Chen, Ling and Xiong, Xiaoli},
title = {An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.114265}
}
EUVIMED